DeFronzo RA, Goodman AM: Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med. 1995, 333: 541-549. 10.1056/NEJM199508313330902.
Article
CAS
PubMed
Google Scholar
Johnson JA, Majumdar SR, Simpson SH, Toth EL: Decreased mortality associated with metformin use compared to sulfonylurea monotherapy in type 2 diabetes mellitus. Diabetes Care. 2002, 25: 2244-2248. 10.2337/diacare.25.12.2244.
Article
CAS
PubMed
Google Scholar
UK Prospective Diabetes Study group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998, 352: 854-865. 10.1016/S0140-6736(98)07037-8.
Article
Google Scholar
Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA: Improved Clinical Outcomes Associated With Metformin in Patients With Diabetes and Heart Failure. Diabetes Care. 2005, 28: 2345-2351. 10.2337/diacare.28.10.2345.
Article
CAS
PubMed
Google Scholar
Smooke S, Horwich TB, Fonarow GC: Insulin-treated diabetes is associated with a marked increase in mortality in patients with advanced heart failure. Am Heart J. 2005, 149: 168-174. 10.1016/j.ahj.2004.07.005.
Article
CAS
PubMed
Google Scholar
Canadian Pharmaceutical Association: Compendium of pharmaceuticals and specialties (Canada). 2004
Google Scholar
Inzucchi SE: Metformin and heart failure: innocent until proven guilty. Diabetes Care. 2005, 28: 2585-2587. 10.2337/diacare.28.10.2585.
Article
PubMed
Google Scholar
Inzucchi SE, Masoudi FA, McGuire DK: Metformin in heart failure. Diabetes Care. 2007, 30: e129-10.2337/dc07-1686.
Article
PubMed
Google Scholar
Nichols GA, Gullion CM, Koro CE, Ephross SA, Brown JB: The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care. 2004, 27: 1879-1884. 10.2337/diacare.27.8.1879.
Article
PubMed
Google Scholar
Kannel WB, Hjortland M, Castelli WP: Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 1974, 34: 29-34. 10.1016/0002-9149(74)90089-7.
Article
CAS
PubMed
Google Scholar
Holstein A, Nahrwold D, Hinze S, Egberts EH: Contra-indications to metformin therapy are largely disregarded. Diabet Med. 1999, 16: 692-696. 10.1046/j.1464-5491.1999.00115.x.
Article
CAS
PubMed
Google Scholar
Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM: Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA. 2003, 290: 81-85. 10.1001/jama.290.1.81.
Article
CAS
PubMed
Google Scholar
Misbin RI: The phantom of lactic acidosis due to metformin in patients with diabetes. Diabetes Care. 2004, 27: 1791-1793. 10.2337/diacare.27.7.1791.
Article
PubMed
Google Scholar
Stang M, Wysowski DK, Butler-Jones D: Incidence of lactic acidosis in metformin users. Diabetes Care. 1999, 22: 925-927. 10.2337/diacare.22.6.925.
Article
CAS
PubMed
Google Scholar
Fantus IG: Metformin's contraindications: needed for now. Canadian Medical Association Journal. 2005, 173: 505-507. 10.1503/cmaj.050401.
Article
PubMed
PubMed Central
Google Scholar
Salpeter SR, Greyber E, Pasternak GA, Salpeter EE: Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med. 2003, 163: 2594-2602. 10.1001/archinte.163.21.2594.
Article
PubMed
Google Scholar
Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM: Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005, 111: 583-590. 10.1161/01.CIR.0000154542.13412.B1.
Article
CAS
PubMed
Google Scholar
Horlen C, Malone R, Bryant B, Dennis B, Carey T, Pignone M, Rothman R: Frequency of inappropriate metformin prescriptions. JAMA. 2002, 287: 2504-2505. 10.1001/jama.287.19.2504-a.
Article
PubMed
Google Scholar
McCormack J, Johns K, Tildesley H: Metformin's contraindications should be contraindicated. CMAJ. 2005, 173: 502-504.
Article
PubMed
PubMed Central
Google Scholar
Emslie-Smith AM, Boyle DI, Evans JM, Sullivan F, Morris AD: Contraindications to metformin therapy in patients with Type 2 diabetes – a population-based study of adherence to prescribing guidelines. Diabet Med. 2001, 18: 483-488. 10.1046/j.1464-5491.2001.00509.x.
Article
CAS
PubMed
Google Scholar
Howlett HC, Bailey CJ: A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf. 1999, 20: 489-503. 10.2165/00002018-199920060-00003.
Article
CAS
PubMed
Google Scholar
Levenson D: Patients with both diabetes and heart failure often treated with medications government considers unsafe. Report on Medical Guidelines & Outcomes Research. 2003, 14: 1-7.
Google Scholar
Rachmani R: Metformin in patients with type 2 diabetes mellitus: Reconsideration of traditional contraindications. European Journal of Internal Medicine. 2002, 13: 428-433. 10.1016/S0953-6205(02)00131-0.
Article
CAS
PubMed
Google Scholar
Sulkin TV, Bosman D, Krentz AJ: Contraindications to metformin therapy in patients with NIDDM. Diabetes Care. 1997, 20: 925-928. 10.2337/diacare.20.6.925.
Article
CAS
PubMed
Google Scholar
Eurich DT, McAlister FA, Blackburn DF, Majumdar SR, Tsuyuki RT, Varney J, Johnson JA: Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review. BMJ. 2007, 335: 497-10.1136/bmj.39314.620174.80.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sackett DL: Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle. CMAJ. 2000, 162: 1311-1314.
CAS
PubMed
PubMed Central
Google Scholar
Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW, Maksymowych WP, Steiner IP, Harley CH, Wizba BJ, Hanley DA, Blitz A, Russell AS: A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med. 2004, 141: 366-373.
Article
PubMed
Google Scholar
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee: Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003, 27: s1-s152.
Google Scholar
Tsuyuki RT, Fradette M, Johnson JA, Bungard TJ, Eurich DT, Ashton T, Gordon W, Ikuta R, Komder J, Mackav E, Manyari D, O"Reilly K, Semchuk W: A multicenter disease management program for hospitalized patients with heart failure. J Card Fail. 2004, 10: 473-480. 10.1016/j.cardfail.2004.02.005.
Article
PubMed
Google Scholar
Johnson JA, Pohar SL, Secnik K, Yurgin N, Hirji Z: Utilization of diabetes medication and cost of testing supplies in Saskatchewan, 2001. BMC Health Serv Res. 2006, 6: 159-10.1186/1472-6963-6-159.
Article
PubMed
PubMed Central
Google Scholar
Besner HK, Feemster AA, Bongiorno RA: Evaluation of metformin use in hospitalized patients. Ashp Midyear Clinical Meeting. 2004, 39: 243E-
Google Scholar
Khandwala HM: The prevalence of contraindications to the use of metformin. Can J Diabetes. 2004, 28: 380-384.
CAS
Google Scholar
Canadian Diabetes Association Clinical Practice Guidelines Expert Committe: Canadian Diabetes Association 2008 clincal practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2008, 32 (suppl 1): S1-S201.
Google Scholar
Prescott RJ, Counsell CE, Gillespie WJ, Grant AM, Russell IT, Kiauka S, Colthart IR, Ross S, Shepherd SM, Russell D: Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess. 1999, 3: 1-143.
CAS
PubMed
Google Scholar
Taylor KM, Margolese RG, Soskolne CL: Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med. 1984, 310: 1363-1367.
Article
CAS
PubMed
Google Scholar
Benson AB, Pregler JP, Bean JA, Rademaker AW, Eshler B, Anderson K: Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study. J Clin Oncol. 1991, 9: 2067-2075.
PubMed
Google Scholar
Tognoni G, Alli C, Avanzini F, Bettelli G, Colombo F, Corso R, Marchiolo R, Zussino A: Randomised clinical trials in general practice: lessons from a failure. BMJ. 1991, 303: 969-971.
Article
CAS
PubMed
PubMed Central
Google Scholar
Majumdar SR, McAlister FA, Furberg CD: From knowledge to practice in chronic cardiovascular disease: a long and winding road. J Am Coll Cardiol. 2004, 43: 1738-1742. 10.1016/j.jacc.2003.12.043.
Article
PubMed
Google Scholar
Nichols GA, Hillier TA, Erbey JR, Brown JB: Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care. 2001, 24: 1614-1619. 10.2337/diacare.24.9.1614.
Article
CAS
PubMed
Google Scholar
Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB: Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006, 27: 65-75. 10.1093/eurheartj/ehi555.
Article
PubMed
Google Scholar
Murcia AM, Hennekens CH, Lamas GA, Jimenez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA: Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Archives of Internal Medicine. 2004, 164: 2273-2279. 10.1001/archinte.164.20.2273.
Article
PubMed
Google Scholar
Laupacis A, Mamdani M: Observational studies of treatment effectiveness: some cautions. Ann Intern Med. 2004, 140: 923-924.
Article
CAS
PubMed
Google Scholar
D'Agostino RB, D'Agostino RB: Estimating treatment effects using observational data. JAMA. 2007, 297: 314-316. 10.1001/jama.297.3.314.
Article
PubMed
Google Scholar